CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q3 Özgün Makale Scopus
Relationship of kynurenine pathway metabolites and indoleamine 2,3-dioxygenase with atherosclerosis: data obtained from pericardial fluid in coronary artery bypass surgery
Scandinavian Journal of Clinical and Laboratory Investigation 2025 Cilt 85 Sayı 6
Scopus Eşleşmesi Bulundu
0
Atıf
85
Cilt
509-517
Sayfa
Özet
Analyzing the local pericardial fluid (PF) surrounding the heart can provide insights into the function of myocardial and pericardial epithelial cells. Kynurenine (KYN) metabolites have been associated with endothelial dysfunction and the progression of atherosclerosis. This study investigated the relationship between KYN pathway metabolites in serum and PF and the severity of coronary atherosclerosis, as assessed by the Syntax Score (SS). The study involved 101 patients (mean age: 60 years). Of the participants, 17% were female. KYN and its metabolite levels were measured using API SCIEX 3200 LC-MS/MS methods. Statistical analysis was performed using IBM SPSS 25.0. The mean serum levels of tryptophan (TRP), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthranilic acid were significantly higher (p < 0.01) when compared to the mean PF levels. In the SS-low group, PF IDO activity was significantly higher than serum IDO activity (p = 0.040). In the SS-high group, PF IDO activity was significantly higher than serum IDO activity (p = 0.002). The mean 3-HK measurements showed significant differences between the SS groups (p < 0.05). In this study, higher IDO enzyme activity in the PF compared to systemic circulation suggests the presence of inflammatory activity in the pericardial endothelial cells. This research aimed to uncover the role of amino acid metabolism, which is poorly understood in atherosclerosis. Specifically, 3-HK, a metabolite from the KYN pathway, may contribute to the development of atherosclerosis. These findings indicate that localized kynurenine pathway activation in the PF may contribute to coronary atherosclerosis, highlighting its potential as a biomarker or therapeutic target.
Web of Science Eşleşmesi Bulundu
0
WoS Atıf
85
Cilt
Article
Belge Türü
Kaynak: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION · s. 509-517
Anahtar Kelimeler (WoS)

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2025 yılı verileri
Scandinavian Journal of Clinical and Laboratory Investigation
Q3
SJR Quartile
0,493
SJR Skoru
78
H-Index
Kategoriler: Clinical Biochemistry (Q3) · Medicine (miscellaneous) (Q3)
Alanlar: Biochemistry, Genetics and Molecular Biology · Medicine
Ülke: United Kingdom · Taylor and Francis Ltd.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

WoS | Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.

Makale Bilgileri

Dergi Scandinavian Journal of Clinical and Laboratory Investigation
ISSN 0036-5513
Yıl 2025 / 8. ay
Cilt / Sayı 85 / 6
Sayfalar 509 – 517
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q3
Teşvik Puanı 1,29 · YÖKSİS Akademik Teşvik
Yayın Dili Türkçe
Kapsam Uluslararası
Toplam Yazar 7 kişi
Erişim Türü Basılı+Elektronik
Alan Sağlık Bilimleri Temel Alanı Tıbbi Biyokimya

YÖKSİS Yazar Kaydı

Yazar Adı ÇOMAKLI HAKAN,Bik Mohammad Ahmad,ÜNLÜ ALİ,ABUŞOĞLU SEDAT,YİĞİTBAŞI MEHMET MURAT,Demirsöz Mert,KÜÇÜKER ŞEREF ALP
YÖKSİS ID 9019811

Metrikler

Havuz Atıfları 0
JCR Quartile Q3
Teşvik Puanı 1,29
Yazar Sayısı 7